Back to AVCT Stock Lookup

American Virtual Cloud Technologies (AVCT) – Business Wire

Apr 6, 2021 06:21 AM Avacta Announces Distribution Agreement With ABCAM plc
Mar 8, 2021 02:30 AM Avacta’s Rapid Antigen Test Is Confirmed to Detect SARS-CoV-2 New Variants
Mar 4, 2021 09:15 AM Computex Named to the 2021 Elite 150 in CRN® MSP 500 List
Feb 18, 2021 03:05 AM Avacta Announces Phase 1 Clinical Trial Authorisation (CTA) for AVA6000 Approved by MHRA
Feb 8, 2021 03:59 AM Avacta and Mologic Announce Commercial Partnership
Feb 1, 2021 12:09 PM Avacta announces AffyXell $7.3 Million Series A Financing
Jan 28, 2021 04:19 AM Avacta Announces Collaboration Agreement With Bruker
Jan 11, 2021 09:30 AM Navigation Capital Partners SPAC Operations Significantly Expands SPAC Portfolio
Jan 7, 2021 03:49 AM Avacta Announces License Agreement With POINT Biopharma Inc.
Dec 23, 2020 03:45 AM Avacta Submits Clinical Trial Application for AVA6000 pro-doxorubixin
Dec 21, 2020 03:50 AM Avacta Group plc Signs License Agreement With Astrea Bioseparations
Sep 30, 2020 07:20 AM Avacta Launches SARS-CoV-2 BAMS Research Test
Sep 2, 2020 03:56 AM Avacta Expands Rapid SARS-CoV-2 Antigen Test Manufacturing Capacity
Aug 18, 2020 04:06 AM Avacta and LG Chem Life Sciences Expand Partnership
Aug 11, 2020 04:05 AM Avacta Appoints Therapeutics Chief Development Officer
Aug 7, 2020 04:47 AM Avacta Announces SARS-CoV-2 Rapid Antigen Test Clinical Collaboration
Aug 6, 2020 04:16 AM Avacta Appoints COVID-19 Rapid Antigen Test Manufacturing Partner
Jul 29, 2020 05:00 AM Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy
Jul 22, 2020 04:29 AM Avacta provides update on clinical validation of Adeptrix COVID-19 diagnostic test
Jul 13, 2020 04:40 AM Avacta and Integumen plc collaborate for detection of SARS-COV-2 coronavirus in waste water
Jun 24, 2020 03:49 AM Avacta Provides Update on COVID-19 Rapid Antigen Test Development Partnership With Cytiva
Jun 18, 2020 03:58 AM Avacta provides update on Affimer therapy for COVID-19 infection
Jun 9, 2020 04:06 AM Avacta Provides Update on COVID-19 Antigen Diagnostic Test Development With Adeptrix
May 20, 2020 03:50 AM Avacta and Medusa19 Enter Into a Distribution Agreement For COVID-19 Antigen Test
May 15, 2020 04:19 AM Avacta Develops SARS-COV-2 Neutralising Affimer Reagents with Therapeutic Potential for COVID-19
May 11, 2020 12:38 PM Avacta Ships SARS-COV-2 Affimer Reagents to Cytiva and Adeptrix
May 1, 2020 04:13 AM Avacta Group plc Forms COVID-19 Antigen Diagnostic Collaboration With Adeptrix
Apr 27, 2020 11:12 AM Navigation Capital Partners’ Portfolio Company Computex Sold to American Virtual Cloud Technologies
Apr 22, 2020 04:02 AM Avacta Successfully Generates Several Highly Specific Affimer Reagents for COVID-19 Antigen Rapid Test Ahead of Schedule as Part of Cytiva Partnership
Apr 8, 2020 04:13 AM Avacta and Cytiva Collaborating on COVID-19 Rapid Test
Feb 3, 2020 03:48 AM Avacta and Daewoong Agree Collaboration and License Agreement with AffyXell Therapeutics
Jan 28, 2020 08:27 AM Avacta’s Proprietary TMAC Cancer Therapy Platform Demonstrates Successful Proof-of-Concept in Pre-Clinical Study
Jan 21, 2020 05:20 AM Avacta Group plc Appoints Paul Fry as Non-Executive Director
Jan 8, 2020 04:24 AM Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture
Nov 13, 2019 04:30 AM LG Chem Life Sciences Expands Partnership with Avacta Group plc
Oct 10, 2019 03:41 AM Avacta Group plc Enters Collaboration and Option Agreement With ADC Therapeutics

Back to AVCT Stock Lookup